Skip to content

Author

A. Martins

We have 2 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Multi-Target Analysis of Xanthone Derivatives as Potential Anti-Trypanosoma cruzi Agents: An Integrated Computational Screening

In silico results highlight XN5 as a promising candidate for Chagas disease treatment, showing multi-parameter optimization scores of 5, molecular weights below 400 g/mol, and advantageous absorption and permeability profiles.

Rafael de Oliveira Marinho, Caroline Do Nascimento Gonçalves, Jacilene Silva et al. · 0 citations
Open access Jul 2026

Evaluation of Chalcone (E)‑3-(4-Fluorophenyl)-1-(2-hydroxy-3,4,6-trimethoxyphenyl)-prop-2-en-1-one against Trypanosoma cruzi (Y Strain): In Vitro Assay, In Silico Drug-Target Analysis, and MPO-Based Drug Likeness

The CPN4F molecule demonstrates potent in vitro efficacy against Chagas disease, outperforming BZN in molecular docking studies targeting cruzain and outperforming BZN in molecular docking studies targeting cruzain.

J. Pinto, Francisco Nithael Melo Lucio, L. R. Ribeiro et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.